Biohaven
BHVN
11.88
-0.20
-1.66%
Biohaven
US · BHVN
#2805 by market cap
Listed 2017
11.88
-0.20
-1.66%
Live - 5344 symbols - heartbeat 472s ago
· 2026-10-08 06:47
Pre-market
12.25
+3.11%
After-hours
11.88
0.00%
Overnight
11.88
0.00%
- Market cap
- 1.79B
- P/E (TTM)i
- -2.61
- P/Bi
- 146.67
- EPSi
- -6.86
- Div yieldi
- 0.00%
- 52W posi
- 40%
Reader sentiment
Are you bullish or bearish on BHVN?
Anonymous reader poll. Unscientific, not investment advice.
About Biohaven
Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.
- Founded
- 2022
- CEO
- Dr. Vlad Coric, M.D.
- Employees
- 274
- Headquarters
- New Haven, Connecticut, United States of America
- Fiscal year end
- 12-31
- Website
- biohaven.com
Company profile
- Exchange
- US
- Symbol
- BHVN
- Market-cap rank
- #2805
- Listing date
- 2017-05-04
- Market cap
- 1.79B
- Float cap
- 1.38B
- Shares out
- 151.04M
- Float shares
- 116.57M
Sectors & themes
Biotechnology
Fractional Shares JP
Quote time 2026-10-08 06:47:26 · For reference only, not investment advice and not tailored to your situation.